Zalcitabine is a pyrimidine 2′,3′-dideoxyribonucleoside compound having cytosine as the nucleobase. Among its listed roles, it functions as a antiviral drug, an antimetabolite and a HIV-1 reverse transcriptase inhibitor. It is grouped under the following drug class(es): Dideoxynucleosides, DNA polymerase inhibitors, Nucleosides and Reverse Transcriptase Inhibitors. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Zalcitabine, Zalcitabina and Zalcitabinum. Its PubChem CID is 24066.
Dideoxycytidine
| CAS No | 7481-89-2 |
|---|---|
| Molecular Formula | C9H13N3O3 |
| Molecular Weight | 211.22 g/mol |
| Synonyms | 4-amino-1-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Zalcitabine is a pyrimidine 2',3'-dideoxyribonucleoside compound having cytosine as the nucleobase. Among its listed roles, it functions as a antiviral drug, an antimetabolite and a HIV-1 reverse transcriptase inhibitor.
The listed CAS number is 7481-89-2.
The listed molecular formula is C9H13N3O3.
The listed molecular weight is 211.22 g/mol.
4-amino-1-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one.
The source lists Zalcitabine, Zalcitabina and Zalcitabinum.